Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(510)
•••
Comment by 2b7f6fabon Jul 19, 2019 9:26pm
180 Views
Post# 29942154

RE:RE:RE:RE:RE:RE:RE:NEWS (No Event Worth Speakingabout)

RE:RE:RE:RE:RE:RE:RE:NEWS (No Event Worth Speakingabout)Agreed, but The Dogshit moves the embassy to Jewrusalem.


2b7f6fab wrote: Agreed Trump has been a major disappointment.  I voted for the Trump to close the borders from the brown horde of illegals.  And also to get Americans out of kike wars in the middle east.  Isn't it too bad that we can't use Theralase lasers on the 60 some odd duel citizen pieces of annus occupying the congress and senate?  I'm coming to the conclustion that all you Canadains don't have two brain cells to rub together.

Macer wrote:
enriquesuave wrote: Could it be that patient or patients have been treated, but just waiting on 7 days initial safety time point to pass before PMH makes an announcement?  I hope so, but sooner or later we will hear something.  


Not worried at all about enrollement at PMH. They are approved and ready to go. We can expect the same pace of enrollement as phase 1 from PMH.
I am interested in bring on more sites, this will be a catalyst.
FDA application should be a significant boost. Approval and site enrollement in the US will be music to our ears.
If they could only use the laser to treat the cancer in the oval office!
Macer
 




Bullboard Posts
Dealroom for high-potential pre-IPO opportunities